Default object view. Click to create a custom template, Node ID: 115273, Object ID: 68840

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multic...

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study

No relation

Yes

No relation

No

24/06/2015 3:57 pm

No